MiMedx Group, Inc (MDXG) analyst actions
Rating and price-target actions on MDXG in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the MDXG overview →
1 measured MDXG analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| MIMEDX Provides AXIOFILL® Update & Reiterates 2023 Full Year Net Sales and Fourth Quarter Adjusted EBITDA Margin Outlook | Press release | -2.23% | -4.95% |
Keep exploring
More MDXG: earnings → · SEC filings → · MDXG overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Cellectar Biosciences, Inc. (CLRB) | 265 | +0.27% | 52% |
| EVOTEC AG S/ADR (EVTCY) | 265 | 0.00% | 17% |
| Relmada Therapeutics, Inc. (RLMD) | 265 | -0.01% | 44% |
| HUTCHMED (China) Limited - American Depositary Shares (HCM) | 263 | 0.00% | 47% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.